Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe revision history now shows version 3.7.0 in place of 3.6.6, reflecting a new page update.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows revision v3.6.6, replacing v3.6.5. This update reflects a new site revision for the page, with no changes to study details or outcomes.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now indicates a new revision tag: v3.6.5, and the previous v3.6.4 tag has been removed. This reflects a routine platform update without changes to the study content or how users interact with the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a site version update and does not change the study content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision metadata was updated from v3.6.0 to v3.6.3, indicating a newer version of the study record.SummaryDifference0.1%

- Check98 days agoChange DetectedNew user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants') have been added to the page. The Intervention header has been renamed to Intervention/Treatment and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.